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Abstract
AIM
To investigate the range of pathologies treated by 
pancreas preserving distal duodenectomy (PPDD) and 
present the outcome of follow-up.
METHODS
Neoplastic lesions of the duodenum are treated 
conventionally by pancreaticoduodenectomy. Lesions 
distal to the major papilla may be suitable for a 
pancreas-preserving distal duodenectomy, potentially 
reducing morbidity and mortality. We present our 
experience with this procedure. Selective intraoperative 
duodenoscopy assessed the relationship of the 
papilla to the lesion. After duodenal mobilisation and 
confirmation of the site of the lesion, the duodenum 
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was transected distal to the papilla and beyond the 
duodenojejunal flexure and a side-to-side duodeno-
jejunal anastomosis was formed. Patients were 
identified from a prospectively maintained database and 
outcomes determined from digital health records with a 
dataset including demographics, co-morbidities, mode 
of presentation, preoperative imaging and assessment, 
nutritional support needs, technical operative details, 
blood transfusion requirements, length of stay, 
pathology including lymph node yield and lymph 
node involvement, length of follow-up, complications 
and outcomes. Related published literature was also 
reviewed. 
RESULTS
Twenty-four patients had surgery with the intent 
of performing PPDD from 2003 to 2016. Nineteen 
underwent PPDD successfully. Two patients planned for 
PPDD proceeded to formal pancreaticoduodenectomy 
(PD) while three had unresectable disease. Median 
post-operative follow-up was 32 mo. Pathologies 
resected included duodenal adenocarcinoma (n  = 6), 
adenomas (n  = 5), gastrointestinal stromal tumours 
(n  = 4) and lipoma, bleeding duodenal diverticulum, 
locally advanced colonic adenocarcinoma and extrinsic 
compression (n  = 1 each). Median postoperative length 
of stay (LOS) was 8 d and morbidity was low [pain 
and nausea/vomiting (n  = 2), anastomotic stricture 
(n  = 1), pneumonia (n  = 1), and overwhelming post-
splenectomy sepsis (n  = 1, asplenic patient)]. PPDD 
was associated with a significantly shorter LOS than 
a contemporaneous PD series [PPDD 8 (6-14) d vs  
PD 11 (10-16) d, median (IQR), P  = 0.026]. The 30-d 
mortality was zero and 16 of 19 patients are alive to 
date. One patient died of recurrent duodenal adeno-
carcinoma 18 mo postoperatively and two died of 
unrelated disease (at 2 mo and at 8 years respectively).
CONCLUSION
PPDD is a versatile operation that can provide definitive 
treatment for a range of duodenal pathologies including 
adenocarcinoma.
Key words: Pancreas preserving distal duodenectomy; 
Duodenojejunostomy; Duodenal disease; Surgical 
technique; Adults; Indications; Treatment; Outcome
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Core tip: Pancreas preserving distal duodenectomy 
is a versatile operation that can provide definitive 
treatment for a range of duodenal pathologies including 
adenocarcinoma. It avoids the morbidity and mortality 
of a pancreaticoenteric anastomosis and can be 
undertaken safely with shorter postoperative length of 
stay than pancreaticoduodenectomy.
Mitchell WK, Thomas PF, Zaitoun AM, Brooks AJ, Lobo DN. 
Pancreas preserving distal duodenectomy: A versatile operation 
for a range of infra-papillary pathologies. World J Gastroenterol 
2017; 23(23): 4252-4261  Available from: URL: http://www.
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INTRODUCTION
The duodenum gives rise to more neoplasia, and 
possibly pathology in general, per unit length, than 
does any other part of the small bowel[1,2]. The 
retroperitoneal position of the duodenum, its shared 
blood supply with the pancreas, and its relationship 
with the ampulla of Vater and the superior mesenteric 
vessels ensure that any duodenal resection is 
potentially a major undertaking. Pancreatico­
duodenectomy (PD) constitutes the mainstay of 
surgical treatment of duodenal lesions[3] and up to 
10% of PDs are undertaken for lesions that actually 
arise in the duodenum[4]. However, PD is associated 
with significant morbidity and mortality, which is 
due in part to pancreatic resection and anastomosis. 
Moreover, it is likely that the actual risks associated 
with PD are widely underestimated[5]. 
Duodenal resection with pancreas preservation 
is possible and has been used in the treatment of a 
range of duodenal conditions. Pancreas preserving 
total duodenectomy is an option for the treatment of 
diffuse non­invasive mucosal disease such as FAP­
associated polyposis[6,7] whilst pancreas preserving 
distal duodenectomy (PPDD) has been described in the 
treatment of a range of benign and malignant lesions 
arising distal to the papilla complex[8,9]. 
We describe how we perform a PPDD and present 
the long­term results of a series of 19 patients who 
underwent the procedure in a single centre for a 
variety of pathologies over a 14­year period and also 
review the relevant literature.
MATERIALS AND METHODS
Preoperative investigations and preparation
This procedure is usually undertaken in an elective 
or scheduled capacity for patients with infra­papillary 
conditions that, in the opinion of the multidisciplinary 
team, warrant surgical resection. Criteria include M0 
duodenal adenocarcinoma; large adenomata or those 
in positions that prevent effective endoscopic mucosal 
resection; and gastrointestinal stromal tumours. 
Patients routinely undergo multi­slice pancreas pro­
tocol computed tomography (CT) with occasional 
fluoroscopic investigations. Most have one or more 
modalities of endoscopic investigation. Poor nutritional 
status at presentation is considered an indication 
for nasojejunal feeding which is commenced 7­14 
d preoperatively. Representative CT and endoscopic 
findings are shown in Figures 1­3. The relationship 
of the tumour or lesion to the ampulla of Vater on 
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preoperative endoscopy or CT is vital in determining 
the feasibility of offering the patient a PPDD. 
Nevertheless, the procedure should only be undertaken 
in an institution with expertise and facilities to perform 
a PD, as a small number of patients will not be suitable 
for a PPDD on surgical exploration because of close 
proximity of a malignant pathology to the ampulla or 
involvement of the pancreas by the malignant process. 
This should be considered in the consent process and 
we usually obtain consent to perform a PPDD with a 
view to proceed to a PD or perform a bypass procedure 
in the event of unresectability.
Operative technique
Arterial, central venous, epidural and bladder cathe­
terisations are performed for monitoring and pain 
relief. Flow­guided intraoperative fluid therapy is 
used. In cases where there is concern regarding 
the proximity of the lesion to the ampulla, their 
relationship is confirmed intraoperatively with side­
viewing duodenoscopy. A transverse upper abdominal 
incision with appropriate fixed table retraction is 
used. The key operative steps are shown in Figure 4. 
Wide Kocherisation of the duodenum is undertaken, 
facilitated by a variable degree of right medial visceral 
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Figure 1  Representative axial computed tomography imaging of duodenal adenocarcinoma. A and B: obstruction due to a large duodenal mass (same patient); 
C: exophytic mass without obstruction; D: subtle thickening of duodenum and periduodenal fat stranding reported as duodenitis, but in fact was a malignant tumour on 
post resection histology.
A B C
Figure 2  Representative coronal computed tomography imaging of duodenal adenocarcinoma. A: thickening of the duodenal wall with non-obstructive 
narrowing; B: mass in the distal duodenum, C: stricture of D2/3 junction with some obstructive features.
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Figure 3  Endoscopic features. A: pedunculated lesion (gastrointestinal stromal tumour); B: sessile lesion (large adenoma with previous endoscopic mucosal 
resection); C and D: malignant ulceration of a duodenal adenocarcinoma.
A B C
D E
Figure 4  Operative technique. After wide Kocherisation (A) the papilla and lesion are palpated. For benign pathology close to the papilla, the ampullary complex can 
be further protected by cannulation (B). The proximal jejunum is transected (C), the distal duodenum taken off its short vessels and the resection is completed (D). 
Reconstruction is by a retrocolic isoperistaltic side-to-side duodenojejunostomy (E).
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rotation (Cattell­Braasch manoeuver)[10]. Resectability 
is determined by excluding involvement of the pan­
creas and peripancreatic vessels and by confirming 
macroscopic proximal clearance of at least 10 mm with 
preservation of the major papilla complex. Macroscopic 
nodal and distant metastatic disease are also excluded. 
Frozen section biopsies are taken when necessary. 
After confirming resectability, the proximal jejunum 
is transected with a transverse linear cutting stapler 
and its mesentery, along with the ligament of Treitz 
and the peritoneal attachments of the duodenojejunal 
junction, are divided to permit delivery of the proximal 
jejunum behind the superior mesenteric vessels into 
the supracolic compartment. The third part of the 
duodenum (D3) and distal second part (D2) are then 
separated from the pancreatic head and uncinate 
process. The mobile, devascularised distal duodenum 
is then excised, again with linear stapler. For benign 
lesions close to the papilla, the latter is cannulated with 
a 4F infant feeding tube via a duodenotomy to facilitate 
proximal transection with preservation of the ampullary 
complex. PD is undertaken if the lesion involved to 
papilla. The proximal, blind end of jejunum is delivered 
through a window in the transverse mesocolon to 
permit a sutured side­to­side isoperistaltic duodeno­
jejunostomy, which is performed with 3­0 or 4­0 
polydioxanone (PDS®II, Ethicon, Edinburgh, United 
Kingdom) sutures in a single continuous layer. In cases 
assessed at risk of malnutrition or anticipated delayed 
gastric emptying, as in patients with preoperative 
gastric outlet obstruction, a fine bore nasojejunal 
feeding tube is placed across the anastomosis for 
postoperative feeding. A cholecystectomy is performed 
if the gallbladder is still in situ. A peritoneal drain is 
placed selectively if there is of a perceived risk of 
postoperative pancreatic fistulation following dissection 
on or close to the pancreas.
Postoperative management
Postoperative care is initially in a surgical high de­
pendency unit and has, in recent years, proceeded 
according to enhanced recovery after surgery (ERAS) 
principles[11]. Somatostatin analogues are not used 
routinely. The peritoneal drain, if used, is removed on 
the third postoperative day provided fluid amylase 
does not exceed three times serum amylase and there 
is no evidence of enteric content.
RESULTS
All patients undergoing PPDD within a large teaching 
hospital were identified using a prospectively 
maintained database and crosschecked against a 
hospital database of pathology specimens. Electronic 
healthcare records were reviewed for relevant in­
formation.
Between 2003 and 2016, 24 patients were 
explored with the intention of performing PPDD. In 
3 patients, malignant involvement of the superior 
mesenteric artery precluded resection and palliative 
gastroenterostomy was undertaken. Two patients 
had intraoperative findings that necessitated PD, as 
the malignant process was close to the papilla and 
adequate resection margins could not have been 
obtained without a PD. Thus, 19 patients proceeded 
to PPDD. Median Charlson co­morbidity index was 
4 (range 0­6). Patient characteristics and modes of 
presentation and are shown in Table 1. Either of two 
surgeons (DNL, AJB) oversaw each operation.
All patients survived 30 d and to discharge home. 
Two of nineteen patients required blood products and 
median postoperative length of stay was 8 d (range 
4­21) The Mann­Whitney test was employed to 
compare length of stay (LOS) following PPDD vs PD 
undertaken in the same centre, using a continuous 
series of PD, February to August 2015 (n = 26). PPDD 
was associated with a significantly shorter LOS than 
PD [8 (6­14) d vs 11 (10­16) d, median (IQR), P = 
0.026] No procedure­related deaths were observed 
in this series and only 1 patient went on to die of 
related disease within the follow up period. This patient 
developed distant recurrence (transcoelomic spread to 
rectouterine pouch). Neoplastic conditions accounted 
for 17 (90%) of operations (Table 2). Median (IQR) 
follow­up was 36 (11­114) mo. Representative images 
of pathological specimens are shown in Figure 5.
DISCUSSION
In our experience, PPDD provides a valuable surgical 
treatment for a range of infra­papillary pathologies, 
which were in the most part neoplastic, including 
duodenal adenocarcinomas (n = 6, 32%), adenomas (n 
= 5, 26%) and gastrointestinal stromal tumours (n = 4, 
21%).
PPDD avoids the potential complications associated 
with a pancreaticoenteric anastomosis. Although 
the infrequency of PPDD, along with differences in 
underlying disease, prevented meaningful comparison 
of morbidity and mortality between PD and PPDD, 
a significantly shorter median length of stay was 
observed following PPDD than PD.
Neither cross­sectional imaging nor forward­
viewing endoscopies provide a detailed description of 
the relationship of the lesion to the papilla. For this 
reason, patients had consented to PD and selected 
cases underwent side­viewing on­table endoscopy and 
duodenotomy/papillary cannulation. The authors would 
advocate that PPDD should only be undertaken where 
expertise and facilities support progression to PD.
Eight of the nineteen PPDD undertaken in this 
14­year period were performed in the last two years. It 
is likely that this reflects changes in referral patterns to 
the centre and an increase in the population catchment 
area, and better awareness of the option of pancreas 
preservation may have contributed to this increase. 
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Table 1  Patient characteristics
No. Age Sex Presentation Comorbidities CCI Radiological 
assessment
Endoscopic 
assessment
Nutritional 
support
Year
1 67 M Asymptomatic (incidental on OGD) Coeliac disease   4 CT OGD, EUS 2011
2 56 F Weight loss, anaemia, vomiting Malnutrition   3 CT, Ba study OGD NJ 2004
3 66 F Vomiting Asthma, depression   4 CT - 2015
4 51 M Epigastric pain, weight loss, 
vomiting
Nil   3 CT OGD 2016
5 68 M Epigastric pain, vomiting Hiatus hernia   4 CT - 2015
6 77 M Epigastric pain, weight loss, 
vomiting, anaemia
Bronchiectasis, GORD   6 CT OGD, enteroscopy 2016
7 73 F Anaemia Metachronous colonic 
cancer
10 CT - 2016
8 61 M Asymptomatic (incidental on 
ultrasound)
GORD   4 CT OGD, EUS 2013
9 48 F Epigastric pain, weight loss, 
vomiting
Nil   2 CT OGD, EUS 2014
10 65 M Asymptomatic (incidental on 
aneurysm screening)
Nil   4 CT OGD, EUS 2016
11 83 F Epigastric pain, weight loss, 
vomiting
Glaucoma, 
hypothyroidism
  6 CT - 2016
12 76 F Dyspepsia/reflux NASH, cirrhosis, 
colectomy for cancer
  4 CT OGD 2008
13 76 M Epigastric pain, back pain Functional asplenia   3 CT OGD, EUS 2006
14 76 M HTN, Stroke, MI   5 - OGD 2007
15 64 F Dyspepsia/reflux Hiatus hernia   2 CT OGD, EUS 2004
16 68 F Epigastric pain, vomiting, early 
satiety
Stricture post EMR   1 CT, Wat Sol St OGD, EUS NJ 2016
17 36 M Recurrent pancreatitis Nil   0 CT OGD 2003
18 80 F Melaena Glaucoma   4 CT OGD 2004
19 39 F Epigastric pain, weight loss, 
vomiting
Nil   0 CT, Wat Sol St OGD 2016
Ba: Barium; CCI: Charlson comorbidity index; CT: Computed tomography; EMR: Endoscopic submucosal resection; EUS: Endoscopic ultrasound; 
GORD: Gastroesophageal reflux disease; HTN: Hypertension; MI: Myocardial infarction; NASH: Non-alcoholic steatohepatosis; NJ: Nasojejunal; OGD: 
Oesophagogastroduodenoscopy; Wat Sol St: Water soluble contrast study.
15 cm 3.4  cm
0    2    4    6    8   10 mm 0    2    4    6    8   10 mm 0 0.5 1 1.5 2 2.5 3 mm
A
B
C
D
E
F
Figure 5  Pathological findings. A and B: exophytic lesion in the duodenum shown to be a moderately differentiated duodenal adenocarcinoma on histology 
(haematoxylin and eosin stain); C and D: gastrointestinal stromal tumour confirmed on immunohistochemistry with CD117 and DOG1 staining; E and F: tubulovillous 
adenoma of the duodenum with low-grade dysplasia on histology (haematoxylin and eosin stain). 
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This raises the possibility that the technique of PPDD 
is underused and improved surgical awareness may 
prevent some patients undergoing unnecessary 
pancreatic resection with an associated longer hospital 
stay and likely increased morbidity and mortality.
To the knowledge of the authors, this series brings 
to 83 the total number of patients undergoing PPDD 
that have been reported in published literature, which 
comprises 4 other series and 10 reports of individual 
cases[3,8,9,12­22]. These are summarized in Table 3. 
Represented pathologies include 27 adenocarcinomas 
of the duodenum (33%), 20 gastrointestinal stromal 
tumours (24%), 12 adenomas (14%) and 5 trauma 
(6%) as well as lipoma and liposarcoma, locally invading 
colon cancer, metastases from seminoma and lung 
cancer, Crohn’s disease, plasmacytoma and lymphoma. 
Technical variation includes different longitudinal extent 
of resection and different anastomotic technique 
with end­to­end, end­to­side and side­to­side all 
represented. Three deaths within 30 d of PPDD have 
been reported; 2 due to cholecystitis and one due to 
anastomotic leak; giving a periprocedural mortality 
of 3.7%. Of the 27 patients undergoing PPDD for 
adenocarcinoma, 10 deaths were recorded and of 
the 17 patients alive at the time of publication of the 
individual reports, 7 had survived more than 36 mo. 
Procedural morbidity included cholangitis/ cholecystitis, 
anastomotic bleeding, delayed gastric emptying and, 
unexpectedly, pancreatic fistulae. Overall, morbidity was 
reported in 32 patients (39%).
Laparoscopic[3,16] and laparoscopic­assisted[23] 
approaches to distal duodenal resection have also 
been described and may offer patients the expected 
benefits of minimally invasive surgery. However, an 
open approach may be better to achieve adequate 
assessment and margins for lesions close to the papilla. 
Table 2  Pathology and outcome 
No. Diagnosis Total lymph 
nodes
Nodes 
+ve
Proximal 
margin (mm)
Blood transfusion 
(units)
Length of stay 
(d)
FU (mo) Complications Outcome
1 Adenocarcinoma Mod diff 
pT4 Nx Mx G2 V0 R0
  0 - 15 0   4   72 - Alive, disease 
free2
2 Adenocarcinoma Mod diff 
pT3 N0 Mx G2 V1 R0
  4   0 55 NR 14 155 - Alive, disease 
free
3 Adenocarcinoma Mod diff T4 
N1 Mx V0 G2 R0
11   1 30 0 13    181 Recurrence Died (distant 
metastases)2
4 Adenocarcinoma Poorly diff 
T4 N2 Mx V1 G3 R0
29 16 62 0   5   13 - Alive, disease 
free2
5 Adenocarcinoma Mod diff 
pT3 N0 M0 V1 G2 R0
  7   0 30 0 14   15 Incisional 
hernia at 1 yr
Alive, disease 
free
6 Adenocarcinoma Mod diff 
pT3 N0 Mx V1 G2 R0
19   0 25 0   6     7 - Alive, disease 
free
7 Adenocarcinoma of colon 10   1 2   7 100 - Alive, disease 
free2
8 GIST (low grade malignant 
potential)
  0   0 0   4   48 - Alive, disease 
free
9 GIST (low grade malignant 
potential)
  0   0 0 10   36 Anast. 
stricture; GJ at 
2 yr
Alive, disease 
free
10 GIST (low grade malignant 
potential)
  1   0 0   8   10 - Alive, disease 
free
11 GIST (low grade malignant 
potential)
  6   0 0   6     5 - Alive, disease 
free
12 Villous adenoma (high grade 
dysplasia)
NR - 8 19      21 Ascitic leak 
(cirrhotic)
Died of 
unrelated causes
13 Tubulovillous adenoma (high 
grade dysplasia)
NR - NR 21 126 OPSI Alive, disease 
free
14 Tubular adenoma (high 
grade dysplasia)
NR - 0   8  1021 - Died of 
unrelated causes
15 Tubular adenoma (low grade 
dysplasia)
NR - 0 18 146 Postoperative 
pneumonia
Alive, disease 
free
16 Multiple tubular adenomas 
(low grade dysplasia)
  1   0 0   7     8 - Alive, disease 
free
17 Lipoma NR - NR 10 168 - Alive, disease 
free
18 Bleeding duodenal 
diverticulum
NR - NR 13 144 - Alive, disease 
free
19 Superior mesenteric artery 
syndrome
NR - 0   5   12 Poor pain 
control, N&V
Alive, disease 
free
1Postoperative death; 2Received adjuvant chemotherapy. Mod diff: Moderately differentiated; NR: Not relevant; GIST: Gastrointestinal stromal tumour; GJ: 
Gastrojejunostomy; OPSI: Overwhelming postsplenectomy infection; N&V: Nausea and vomiting.
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Concern may exist regarding the oncological 
effectiveness of PPDD. We suggest that no evidence 
exists to show benefit of including a pancreatic 
resection in the treatment of a distal duodenal cancer. 
This study shows that an adequate lymphadenectomy 
may be achieved with PPDD (Table 2). Consistent R0 
margin status and adequate histopathological proximal 
resection margins have been achieved by conversion 
to PD if intraoperative doubt exists regarding the 
macroscopic relationship of the disease to surrounding 
structures. The only pattern of recurrence observed 
in this series was distant spread to pelvic peritoneum 
(after resection of T4 lesion with serosal involvement) 
and the authors propose that there would have been 
no oncological benefit from the addition of pancreatic 
head resection. An algorithm describing pre­ and 
intraoperative decision making is presented (Figure 6). 
PPDD is a valuable technique for the treatment 
of a wide range of infra­papillary duodenal lesions 
and an expanding body of published literature exists 
to support its use. It should be undertaken where 
expertise and facilities permit conversion to PD if 
Table 3  Published reports of distal duodenectomy 
First Author Year No. of cases Histology Anastomosis Complications Outcome
Kerremans et al[8] 1979   1 1 adenocarcinoma - Jejunocutaneous fistula Death at 20 mo
Kawano et al[9] 1995   1 1 GIST 1 end-to-side - NR
Maher et al[12] 1996 24 11 adenocarcinomas 10 end-to-end 1 death (anastomotic leak) Adenocarcinoma; 
1 GIST 8 end-to-side 2 pancreatic fistulae Median survival 18.5 mo
2 adenomas 3 side-to-end 2 DGE GIST; NR
1 lymphoma 3 side-to-side 2 anastomotic bleeds
1 liposarcoma
2 Crohn’s disease
5 trauma
1 peptic ulceration
Sohn et al[13] 1998   2 2 adenocarcinomas NR 2 cholangitis NR
Suzuki et al[14] 1999   1 1 GIST 1 end-to-side DGE Alive/ well 2 yr postop
Orda et al[15] 2000   1 1 GIST end-to-end - Alive/ well 13 yr postop
Ammori[16] 2002   1 1 benign stricture side-to-side Intra-abdominal bleeding NR
Eisenberger et al[17] 2004   1 1 GIST NR - Alive/ well 1 yr postop
Spalding et al[18] 2007 14 5 adenocarcinomas 14 end-to-end 1 death (cholecystitis) Adenocarcinoma; 1 death at 
3 mo,
4 GIST 1 anastomotic stricture 
(reoperated)
Median survival 56 mo.
1 adenoma 1 DGE
1 lipoma 1 anastomotic bleed 
(reoperated)
GIST; 1 death at 3 mo,
1 metastatic seminoma Median survival 120 mo 
1 ulcer  
1 plasmacytoma
Cavaniglia et al[19] 2012   1 1 GIST 1 end-to-end - NR
Stauffer et al[3] 2013   1 5 adenomas 7 side-to-side 1 DGE NR 
2 adenocarcinomas 2 end-to-side 1 pancreatic fistula
1 lymphangiolipoma gastrojejunostomy
1 GIST
1 NET
Waisberg et al[20] 2013   1 1 carcinoid NR NR Death at 6 mo
Shimizu et al[21] 2015   1 1 adenoma 1 end-to-side NR NR
García-Molina et al[22] 2015   8 1 adenocarcinoma 1 death Adenocarcinoma; 1 death at 
12 mo
5 GIST
1 metastasis from lung GIST; 5 Alive/ well at 4-6 yr
1 colon cancer
Current series 2017 19 6 adenocarcinomas 19 side-to-side 1 recurrent adenocarcinoma Adenocarcinoma: 1 death at 
18 mo 
5 adenomas 1 anastomotic Stricture Alive/well 1 < 1 yr, 2 > 1 yr, 
1 > 6 yr, 1 > 12 yr
4 GIST 1 incisional hernia GIST: Alive/ well 2 < 1 yr, 2 
> 3 yr
1 lipoma
1 colon cancer
1 bleeding diverticulum
1 extrinsic compression
DGE: Delayed gastric emptying; GIST: Gastrointestinal stromal tumour; NET: Neuroendocrine tumor; NR: Not recorded.
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necessitated by intraoperative findings.
COMMENTS
Background
Neoplastic lesions of the duodenum are treated conventionally by 
pancreaticoduodenectomy. Lesions distal to the major papilla may be suitable 
for a pancreas-preserving distal duodenectomy (PPDD), potentially reducing 
morbidity and mortality. Limited awareness of this technique may deprive 
patients of the opportunity to avoid pancreas-specific complications following 
treatment for infrapapillary diseases.
Research frontiers
Early series suggested poor outcomes after PPDD for duodenal adeno-
carcinoma. Adenocarcinoma may thus be considered a contentious indication 
for PPDD. 
Innovations and breakthroughs
The authors widen the range of conditions treated with this surgery, provide 
detail on lymph node harvests, demonstrate a shorter length of stay than after 
pancreaticoduodenectomy, and we present relatively good outcomes after 
PPDD for adenocarcinoma.
Applications
This work supports the consideration of PPDD in the resection of any 
infrapapillary lesion but demonstrates that, in a minority of patients, 
intraoperative findings may mandate proceeding to a formal pancreatico-
duodenectomy. 
Terminology
The authors consider a circumferential full thickness resection of an 
infrapapillary portion of the duodenal tube without macroscopic resection of 
pancreas to constitute a pancreas-preserving distal duodenectomy; this is 
typically after full Kocherisation and with a primary duodenojejunal anastomosis. 
Peer-review
It's a well-written manuscript. The authors described surgical technique and its 
results of pancreas preserving distal duodenectomy.
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